Xtant Medical Holdings, Inc. (XTNT) stock
XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 9/3074% below fair value
$0.28−0.00 (-0.94%)
Close on Nov 12, 2026Market cap $38.62MP/E –Yield –
Xtant Medical r&d expenses
Research and development expenses are spending on new products and technology.
Xtant Medical's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.22M, down 0.4% year over year. For fiscal 2025 it was $2.10M, down 11.9% from the year before. Over ten years it grew -1.9% a year on average. The highest annual figure on record is $3.41M in fiscal 2016.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.10M | -11.9% |
| FY2024 | Dec 31, 2024 | $2.39M | +78.5% |
| FY2023 | Dec 31, 2023 | $1.34M | +46.0% |
| FY2022 | Dec 31, 2022 | $915.00K | +5.2% |
| FY2021 | Dec 31, 2021 | $870.00K | +32.4% |
| FY2020 | Dec 31, 2020 | $657.00K | -29.5% |
| FY2019 | Dec 31, 2019 | $932.00K | -45.2% |
| FY2018 | Dec 31, 2018 | $1.70M | -30.3% |
| FY2017 | Dec 31, 2017 | $2.44M | -28.4% |
| FY2016 | Dec 31, 2016 | $3.41M | +33.9% |
| FY2015 | Dec 31, 2015 | $2.55M | +76.5% |
| FY2014 | Dec 31, 2014 | $1.44M | +152.1% |
| FY2013 | Dec 31, 2013 | $572.36K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $695.00K | +22.8% |
| Q1 FY2026 | Mar 31, 2026 | $435.00K | -1.8% |
| Q4 FY2025 | Dec 31, 2025 | $459.00K | -12.1% |
| Q3 FY2025 | Sep 30, 2025 | $634.00K | -9.6% |
| Q2 FY2025 | Jun 30, 2025 | $566.00K | -11.0% |
| Q1 FY2025 | Mar 31, 2025 | $443.00K | -15.9% |
| Q4 FY2024 | Dec 31, 2024 | $522.00K | +6.1% |
| Q3 FY2024 | Sep 30, 2024 | $701.00K | +43.1% |
| Q2 FY2024 | Jun 30, 2024 | $636.00K | +253.3% |
| Q1 FY2024 | Mar 31, 2024 | $527.00K | +202.9% |
| Q4 FY2023 | Dec 31, 2023 | $492.00K | +112.1% |
| Q3 FY2023 | Sep 30, 2023 | $490.00K | +114.0% |
| Q2 FY2023 | Jun 30, 2023 | $180.00K | -25.3% |
| Q1 FY2023 | Mar 31, 2023 | $174.00K | -18.3% |
| Q4 FY2022 | Dec 31, 2022 | $232.00K | +53.6% |
| Q3 FY2022 | Sep 30, 2022 | $229.00K | -12.6% |
| Q2 FY2022 | Jun 30, 2022 | $241.00K | -0.8% |
| Q1 FY2022 | Mar 31, 2022 | $213.00K | -0.5% |
| Q4 FY2021 | Dec 31, 2021 | $151.00K | +18.0% |
| Q3 FY2021 | Sep 30, 2021 | $262.00K | +48.9% |
| Q2 FY2021 | Jun 30, 2021 | $243.00K | +118.9% |
| Q1 FY2021 | Mar 31, 2021 | $214.00K | -12.7% |
| Q4 FY2020 | Dec 31, 2020 | $128.00K | -50.2% |
| Q3 FY2020 | Sep 30, 2020 | $176.00K | -13.3% |
| Q2 FY2020 | Jun 30, 2020 | $111.00K | -47.1% |
| Q1 FY2020 | Mar 31, 2020 | $245.00K | -6.5% |
| Q4 FY2019 | Dec 31, 2019 | $257.00K | -50.9% |
| Q3 FY2019 | Sep 30, 2019 | $203.00K | -41.5% |
| Q2 FY2019 | Jun 30, 2019 | $210.00K | -49.8% |
| Q1 FY2019 | Mar 31, 2019 | $262.00K | -36.7% |
| Q4 FY2018 | Dec 31, 2018 | $523.00K | -12.5% |
| Q3 FY2018 | Sep 30, 2018 | $347.00K | -31.2% |
| Q2 FY2018 | Jun 30, 2018 | $418.00K | -34.7% |
| Q1 FY2018 | Mar 31, 2018 | $414.00K | -40.8% |
| Q4 FY2017 | Dec 31, 2017 | $598.00K | -25.1% |
| Q3 FY2017 | Sep 30, 2017 | $504.00K | -45.7% |
| Q2 FY2017 | Jun 30, 2017 | $640.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $699.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $798.20K | – |
| Q3 FY2016 | Sep 30, 2016 | $928.93K | – |
See a number that looks wrong?